Literature DB >> 8450248

Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen.

B A Araneo1, M L Woods, R A Daynes.   

Abstract

This study sought to establish whether administration of dehydroepiandrosterone (DHEA) or its sulfate derivative to aged mice could effectively correct the immunosenescent phenotype. Supplemental DHEA sulfate and topical DHEA fully corrected the age-associated dysregulated production of T cell lymphokines by cells from all of the different lymphoid organs tested. Either DHEA or DHEA sulfate supplementation promoted enhanced antibody responses against recombinant hepatitis B surface antigen (rHBsAg) by the aged recipients when incorporated directly into the vaccine. When DHEA was provided either topically or was incorporated directly into vaccine, vigorous primary and secondary antibody responses were detected in the aged mice given a single administration of DHEA, regardless of the mode of administration. It was also established that DHEA treatment could enhance specific antibody responses to rHBsAg in aged animals that had previously not been effectively immunized by conventional vaccination procedures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450248     DOI: 10.1093/infdis/167.4.830

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.

Authors:  Dwight R Stickney; Clarence N Ahlem; Elizabeth Morgan; Christopher L Reading; Nanette Onizuka; James M Frincke
Journal:  Am J Transl Res       Date:  2011-04-12       Impact factor: 4.060

2.  Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.

Authors:  David J Radford; Keqing Wang; Joanne C McNelis; Angela E Taylor; Georg Hechenberger; Johann Hofmann; Hema Chahal; Wiebke Arlt; Janet M Lord
Journal:  Mol Endocrinol       Date:  2010-02-19

Review 3.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 4.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury.

Authors:  L Guth; Z Zhang; E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Intervention in the aging immune system: Influence of dietary restriction, dehydroepiandrosterone, melatonin, and exercise.

Authors:  M A Pahlavani
Journal:  Age (Omaha)       Date:  1998-10

Review 7.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

8.  The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance.

Authors:  R Hernandez-Pando; G A Rook
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

9.  Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization.

Authors:  R A Daynes; E Y Enioutina; S Butler; H H Mu; Z A McGee; A Araneo B
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection.

Authors:  Jia-Feng Wu; Wen-Yu Tsai; Yi-Ching Tung; Huey-Ling Chen; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang
Journal:  J Gastroenterol       Date:  2013-06-01       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.